The first commercially available Vasopressin RIA
Vasopressin
Anti-diuretic hormone (ADH), or [Arg8]-Vasopressin (AVP), is a peptide hormone produced by the hypothalamus and stored in the posterior part of pituitary gland. ADH acts on kidneys, concentrating urine by promoting the re-absorption of water from the cortical collecting duct.
Decreased ADH release leads to diabetes insipidus, a condition featuring hypernatremia (increased blood sodium content), pollyuria (excess urine production) and thirst.
Raised ADH levels (Syndrome of Inappropriate Antidiuretic Hormone or SIADH), and the resulting hyponatremia, occurs in diseases of the brain and lung. In the perioperative period, the effects of surgical stress and some commonly used medications (e.g. opiates, syntocinon, anti-emetics) lead to a similar state of excess ADH secretion. This may cause mild hyponatremia for several days.
Vasopressin direct RIA
Role in disease:
• Decreased ADH leads to diabetes insipidus, a condition featuring hypernatremia (increased blood sodium content), polyuria (excess urine production) and thirst.
• Raised ADH (syndrome of inappropriate antidiuretic hormone, SIADH) and resultant hyponatremia occurs in brain diseases and conditions of the lungs. In the peri-operative period, the effects of surgical stress and some commonly used medications lead to a similar state of excess ADH secretion. This may cause mild hyponatremia for several days.
| Advantages of the BUHLMANN VASOPRESSIN RIA: | |
|---|---|
|
Sensitivity: |
1.25 pg/ml |
|
Specificity: |
<0.001% cross-reactivity with Oxytocin |
|
Reproducibility: |
pre-measured standards and two controls |
Product Information
| Vasopressin | Vasopressin Direct | |
|---|---|---|
Method |
125I-RIA | 125I-RIA |
Time to results |
48 h | 48 h |
Sample Type |
1 ml EDTA plasma & urine | 0.8 ml EDTA plasma |
Standard range |
0.63-80 pg/ml | 1.25-80 pg/ml |
Sensitivity |
0.4 pg/ml | 0.75 pg/ml |
Order Code |
RK- AR1 100 tests | RK- VPD 100 tests |
| CE | CE |
| DOWNLOADS | ||||
|---|---|---|---|---|
Instruction
|
Instruction
|
Technical information |
Labelling schedule |
|
English |
[PDF 0.4MB] | [PDF 0.3MB] | [PDF 0.7MB] | 2012 [PDF 150 KB] |
| |
||||
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
| Your local distributor Order About us Job opportunities |
Search
News
The recently launched EntroGen BRAF (V600E/K/D) test, that can be run on your real-time PCR instrument, is now CE-IVD marked
The EntroGen BRAF (V600E/K/D) test is a very useful tool for the detection of important mutations found in melanoma, because it detects, beside the V600E more
INFINITI KRAS-BRAF study from the Basel Institut of Pathology published in the Diagnostic Molecular Pathology journal.
New publication about the INFINITI KRAS assay in the Journal Diagn Mol Path 21/1 2012 14-23, Bihl et al. In this study from the Institute of Pathology at more
Recent publications on BÜHLMANN calprotectin assays
Three very interesting new papers have been published recently. Manz et al. describes the quality and usefulness of the BÜHLMANN calprotectin ELISA in an more
NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND
BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | Customer Relations | About Us |
Contact |